Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
CMPX compared with FULC: revenue, margins and what each company keeps, and the suppliers and customers both name
CMPX
Compass Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
FULC
Fulcrum Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
CMPX
Compass Therapeutics, Inc.
vs
FULC
Fulcrum Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
CMPX: latest quarter is a loss; flow not drawable. FULC: latest quarter not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
CMPX, solid
FULC, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only CMPX
5
—
ABL Bio
unlisted
supplier
—
Adimab
unlisted
supplier
—
B. Riley Securities
unlisted
supplier
—
Elpiscience Biopharmaceuticals
unlisted
supplier
1 more · CMPX chain
›
Shared
0
No shared counterparties.
Only FULC
3
CAMP
CAMP4 Therapeutics
supplier
SNY
Sanofi
customer
—
CAMP4
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
CMPX
Compass Therapeutics, Inc.
Change
0.79
▲
+3.85%
· post 0.79
Mkt cap
$141.6M
Revenue
$850,000
Q2 FY24
FULC
Fulcrum Therapeutics, Inc.
Change
3.71
▼
−1.72%
· post 3.71
Closed
Oct 30 '26
Mkt cap
$283.1M
Revenue
$80M
Q2 FY24
vs
Compare
Closed
Oct 30 '26
CMPX
Compass Therapeutics, Inc.
vs
FULC
Fulcrum Therapeutics, Inc.
0.79
▲
+3.85%
post 0.79
Price
3.71
▼
−1.72%
post 3.71
$141.6M
Mkt cap
$283.1M
Q2 FY24
$850,000
Revenue
$80M
Q2 FY24
Change
Change
CMPX
0.79
▲
+3.85%
vs
FULC
3.71
▼
−1.72%
Closed
Oct 30 '26